MX9703549A - Acido dietilenotriaminopentaacetico estable, unido por el extremo de n: composiciones de la proteina y metodo. - Google Patents

Acido dietilenotriaminopentaacetico estable, unido por el extremo de n: composiciones de la proteina y metodo.

Info

Publication number
MX9703549A
MX9703549A MX9703549A MX9703549A MX9703549A MX 9703549 A MX9703549 A MX 9703549A MX 9703549 A MX9703549 A MX 9703549A MX 9703549 A MX9703549 A MX 9703549A MX 9703549 A MX9703549 A MX 9703549A
Authority
MX
Mexico
Prior art keywords
compositions
dtpa
stable
methods
protein compositions
Prior art date
Application number
MX9703549A
Other languages
English (en)
Spanish (es)
Other versions
MXPA97003549A (en
Inventor
David C Litzinger
Lloyd D Ralph
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MXPA97003549A publication Critical patent/MXPA97003549A/xx
Publication of MX9703549A publication Critical patent/MX9703549A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9703549A 1994-11-17 1995-11-17 Acido dietilenotriaminopentaacetico estable, unido por el extremo de n: composiciones de la proteina y metodo. MX9703549A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34248194A 1994-11-17 1994-11-17
US342481 1994-11-17
PCT/US1995/015072 WO1996015816A2 (fr) 1994-11-17 1995-11-17 Compositions stables de proteines/acide diethylenetriamine pentacetique a liaison n-terminale et procedes associes

Publications (2)

Publication Number Publication Date
MXPA97003549A MXPA97003549A (en) 1998-02-01
MX9703549A true MX9703549A (es) 1998-02-28

Family

ID=23342010

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703549A MX9703549A (es) 1994-11-17 1995-11-17 Acido dietilenotriaminopentaacetico estable, unido por el extremo de n: composiciones de la proteina y metodo.

Country Status (5)

Country Link
EP (1) EP0796113A2 (fr)
JP (1) JPH10509179A (fr)
AU (1) AU709012B2 (fr)
MX (1) MX9703549A (fr)
WO (1) WO1996015816A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO066096A0 (en) * 1996-06-26 1996-07-18 Peptide Delivery Systems Pty Ltd Oral delivery of peptides
US6017876A (en) * 1997-08-15 2000-01-25 Amgen Inc. Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity
ATE420665T1 (de) 1999-01-19 2009-01-15 Molecular Insight Pharm Inc Konjugate des granulozyten-kolonie stimulierenden faktors zur gezielten bildgebung von infektionen und entzündungen
IT201900011013A1 (it) 2019-07-05 2021-01-05 Sapienza Univ Di Roma Composto e composizione radiofarmaceutici per l’imaging con tecnica di Tomografia a Emissione di Positroni (PET) di cellule positive al recettore dell’interleuchina-2, processo per la loro preparazione, relativo kit e loro usi.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234173A (en) * 1989-06-23 1993-10-26 Cancer Res Campaign Tech Alpha-melanocyte stimulating hormone derivative (alphamsh)-targetted moiety conjugate

Also Published As

Publication number Publication date
AU4366796A (en) 1996-06-17
JPH10509179A (ja) 1998-09-08
WO1996015816A3 (fr) 1996-08-08
AU709012B2 (en) 1999-08-19
WO1996015816A2 (fr) 1996-05-30
EP0796113A2 (fr) 1997-09-24

Similar Documents

Publication Publication Date Title
AU4299496A (en) Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods ofpreparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions
IL125311A0 (en) Metal complexes that contain perfluoroalkyl a process for their production a pharmaceutical composition containing the same and use thereof
HUT47863A (en) Process for production of stabilized human protein compositions
HU9502023D0 (en) Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof for use as contrast agents
HU9503174D0 (en) 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
HK1050898A1 (en) Intermediate used for manufacturing cascade polymer complexes.
AU7366687A (en) Coupling agents for radiolabeling proteins
HK1062647A1 (en) Method and kit for imaging organs and tissues, using labelled antibodies
EP0635001A1 (fr) Thio-urees substituees utilisees comme chelateurs bifonctionnels.
ZA94186B (en) Agents for vascular diseases
CA2046654A1 (fr) Proteines radiomarquees pour usage diagnostique ou therapeutique
ATE296312T1 (de) Metalkomplexbildner
HU911929D0 (en) Process for the production of conjugates containing orto ligating functional group from chelate complexes and joint antibodies or antibody fragments and the medical preparations containing thereof
MX9703549A (es) Acido dietilenotriaminopentaacetico estable, unido por el extremo de n: composiciones de la proteina y metodo.
CA2241825A1 (fr) Nouveaux derives d'edta, de dtpa et de ttha monofonctionnalises et leur utilisation en medecine pour la therapie et le diagnostic
ZA949604B (en) Haloaryl-substituted metal complexes pharmaceutical agents containing these complexes, their use in diagnosis, as well as process for the production of the complexes and agents
IL110462A0 (en) Tris(isonitrile)copper(I) sulfate complexes and their preparation
CA2305764A1 (fr) Sels d'acides biliaires de metaux comportant une action physiologique, et utilisation de ceux-ci en therapie
AU8174691A (en) Reducing chelating agents, their technetium and rhenium complexes, process for their production as well as their use in diagnosis and treatment
AU7353400A (en) Macrocyclic chelants for metallopharmaceuticals
ZA9510198B (en) Novel, multiply, substituted dtpa derivatives and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of pharmaceutical agents
MY141501A (en) Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents and processes for their preparation
IT1242026B (it) Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.
HU9503189D0 (en) Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and process their preparation